ATE196296T1 - Dolastatin analog - Google Patents

Dolastatin analog

Info

Publication number
ATE196296T1
ATE196296T1 AT94902676T AT94902676T ATE196296T1 AT E196296 T1 ATE196296 T1 AT E196296T1 AT 94902676 T AT94902676 T AT 94902676T AT 94902676 T AT94902676 T AT 94902676T AT E196296 T1 ATE196296 T1 AT E196296T1
Authority
AT
Austria
Prior art keywords
dolastatin analogue
dolastatin
analogue
novel
chdcheco
Prior art date
Application number
AT94902676T
Other languages
English (en)
Inventor
Andreas Haupt
Bernd Janssen
Kurt Ritter
Dagmar Klinge
Gerhard Keilhauer
Cynthia Romerdahl
Teresa Barlozzari
Xiao-Dong Qian
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE196296T1 publication Critical patent/ATE196296T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Window Of Vehicle (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT94902676T 1992-12-16 1993-12-04 Dolastatin analog ATE196296T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16
PCT/EP1993/003410 WO1994013695A1 (en) 1992-12-16 1993-12-04 Dolostatin analog

Publications (1)

Publication Number Publication Date
ATE196296T1 true ATE196296T1 (de) 2000-09-15

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94902676T ATE196296T1 (de) 1992-12-16 1993-12-04 Dolastatin analog

Country Status (24)

Country Link
US (1) US5502032A (de)
EP (1) EP0674652B1 (de)
JP (1) JPH08504415A (de)
CN (1) CN1057095C (de)
AT (1) ATE196296T1 (de)
AU (1) AU679479B2 (de)
BR (1) BR1100019A (de)
CA (1) CA2151953A1 (de)
CZ (1) CZ286752B6 (de)
DE (1) DE69329425T2 (de)
ES (1) ES2151921T3 (de)
FI (1) FI952961A0 (de)
HR (1) HRP931504B1 (de)
HU (1) HUT72067A (de)
IL (1) IL107987A (de)
NO (1) NO952366L (de)
NZ (1) NZ258882A (de)
PL (1) PL178766B1 (de)
RU (1) RU2132334C1 (de)
SG (1) SG67935A1 (de)
SI (1) SI9300661A (de)
TW (1) TW400335B (de)
WO (1) WO1994013695A1 (de)
ZA (1) ZA939389B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
EP1156803A4 (de) 1999-02-09 2004-03-17 Bristol Myers Squibb Co LACTAM INHIBITOREN DES FXa UND METHODE
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
JP2004518688A (ja) * 2001-01-30 2004-06-24 ブリストル−マイヤーズ　スクイブ　カンパニー ファクターＸａ阻害剤のスルホンアミドラクタムおよびその方法
EP1446110A2 (de) * 2001-10-16 2004-08-18 Structural Bioinformatics Inc. Organoschwefel-hemmer von tyrosinphosphatasen
US7087604B2 (en) 2002-03-08 2006-08-08 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
JP2006525990A (ja) * 2003-05-12 2006-11-16 ファイザー・プロダクツ・インク 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物
US20060135773A1 (en) * 2004-06-17 2006-06-22 Semple Joseph E Trisubstituted nitrogen modulators of tyrosine phosphatases
EP1786421A2 (de) * 2004-07-09 2007-05-23 Cengent Therapeutics, Inc. Sauerstoff/stickstoff-heterozyklus-hemmer von tyrosinphosphatasen
EP1841749A1 (de) * 2004-09-02 2007-10-10 Metabasis Therapeutics, Inc. Thiazol- und thiadiazolderivate als inhibitoren von tyrosinphosphatasen
ES2585357T3 (es) 2005-07-07 2016-10-05 Seattle Genetics, Inc. Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
EP2717916B1 (de) 2011-06-10 2017-03-08 Mersana Therapeutics, Inc. Protein-polymer-wirkstoffkonjugate
US10226535B2 (en) 2012-12-10 2019-03-12 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
KR102178606B1 (ko) 2013-03-15 2020-11-13 자임워크스 인코포레이티드 세포독성 및 유사분열-억제 화합물, 및 이를 사용하는 방법
BR112016015105A8 (pt) 2013-12-27 2018-04-24 Var2 Pharmaceuticals Aps conjugados var2csa-droga
RU2729194C2 (ru) 2013-12-27 2020-08-05 Займворкс Инк. Сульфонамидсодержащие связывающие системы для лекарственных конъюгатов
RU2723651C2 (ru) 2014-09-17 2020-06-17 Займворкс Инк. Цитотоксические и антимитотические соединения и способы их применения
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
EP4400121A1 (de) 2021-09-03 2024-07-17 Toray Industries, Inc. Pharmazeutische zusammensetzung zur behandlung und/oder prävention von krebs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
DK414389A (da) * 1988-08-24 1990-02-26 Merck & Co Inc Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
ATE190983T1 (de) * 1991-08-09 2000-04-15 Teikoku Hormone Mfg Co Ltd Neue tetrapeptidderivate

Also Published As

Publication number Publication date
FI952961A7 (fi) 1995-06-15
ZA939389B (en) 1995-06-15
HRP931504B1 (en) 2001-04-30
FI952961L (fi) 1995-06-15
EP0674652A1 (de) 1995-10-04
CZ157595A3 (en) 1996-01-17
EP0674652B1 (de) 2000-09-13
WO1994013695A1 (en) 1994-06-23
PL309353A1 (en) 1995-10-02
US5502032A (en) 1996-03-26
SG67935A1 (en) 1999-10-19
PL178766B1 (pl) 2000-06-30
NZ258882A (en) 1997-06-24
NO952366D0 (no) 1995-06-15
HU9501754D0 (en) 1995-08-28
IL107987A0 (en) 1994-04-12
IL107987A (en) 1999-10-28
CZ286752B6 (en) 2000-06-14
SI9300661A (en) 1994-06-30
HRP931504A2 (en) 1997-02-28
RU2132334C1 (ru) 1999-06-27
BR1100019A (pt) 2000-07-25
DE69329425T2 (de) 2001-01-18
AU679479B2 (en) 1997-07-03
DE69329425D1 (de) 2000-10-19
NO952366L (no) 1995-06-15
RU95115135A (ru) 1997-06-10
CN1057095C (zh) 2000-10-04
JPH08504415A (ja) 1996-05-14
TW400335B (en) 2000-08-01
AU5695994A (en) 1994-07-04
CA2151953A1 (en) 1994-06-23
CN1095724A (zh) 1994-11-30
HUT72067A (en) 1996-03-28
FI952961A0 (fi) 1995-06-15
ES2151921T3 (es) 2001-01-16

Similar Documents

Publication Publication Date Title
ATE196296T1 (de) Dolastatin analog
MY124487A (en) Dolastatin derivatives, their preparation and use
DK0794961T3 (da) LHRH-antagonistpeptider
DE69620877D1 (de) Arzneimittelformulierungen für il-12
DK0642530T3 (da) Dolastatinderivater
ES2131528T3 (es) Nuevos polipeptidos y su uso.
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
DK0601117T3 (da) Syntetiske tRNA'er
ITRM910146U1 (it) Strumento chirurgico per l'introduzione di protesi peniene.
MY114327A (en) Novel peptides, the preparation and use thereof
DE69403456D1 (de) Inhibitor gegen kollagenaseaktivität und ihn enthaltende kosmetische zubereitung
ATE223427T1 (de) Modifizierte kojibioside analoge
ATE34987T1 (de) Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung.
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
ITRM920415A1 (it) Composizione per uso chirurgico e sua applicazine per irrigazioni chirurgiche.